HealthEquity, Inc.
NASDAQ:HQYMedical - Healthcare Information Services
-$0.54 today
- Market cap
- $8.05B
- Beta
- 0.21
- P/E (TTM)
- 31.4
- EPS (TTM)
- $2.73
Volume 1.29M
Average 0.98M
HQY Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
HealthEquity, Inc.NASDAQ: HQY
Cash & Equivalents · Q2 FY2027 · quarter ended Jul 2026
Cash & equivalents falls 15.9% from a year ago
Cash & equivalents stood at $256M at the end of Q2 FY2027, down 15.9% from a year earlier and down 3.5% from the prior quarter. Over 3 fiscal years it compounded at +7.8% a year.
Context
- Cash & equivalents amounted to 7.8% of total assets at the end of Q2 FY2027, down 1.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -15.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2026
- 318.93M USD
- Year-over-year change
- +7.8%
- 4-year CAGR
- +9.1%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 318.93M | +7.8% |
| FY2025 | 2025-01-31 | 295.95M | -26.7% |
| FY2024 | 2024-01-31 | 403.98M | +58.9% |
| FY2023 | 2023-01-31 | 254.27M | +12.8% |
| FY2022 | 2022-01-31 | 225.41M | — |
Cash & Equivalents vs competitors
How HQY compares with its peers on the latest reported figures
- HQY's Jul 2026 cash & equivalents of $256M is the 2nd highest of the 8 companies compared; the peer median is $74.71M.
- Its year-over-year change of -15.9% is the 3rd highest of 8, against a peer median of -19.4%.
- Cash & equivalents amounts to 7.8% of total assets for HQY, versus a peer median of 11.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $290.97M | -24.8% | -15.9% | 14.5% | |
| Jul 2026 | $256M | -15.9% | +7.8% | 7.8% | |
| Mar 2026 | $211.77M | +256.5% | +9.7% | 69.9% | |
| Mar 2026 | $179.21M | -19.4% | -30.3% | 55.0% | |
| Apr 2026 | $74.71M | -17.8% | -25.2% | 11.2% | |
CTEVClaritev Corporation | Mar 2026 | $21.33M | -7.8% | -63.1% | 0.4% |
| Jun 2026 | $12.65M | -95.6% | -1.7% | 0.2% | |
| Mar 2026 | $3.85M | -43.4% | -36.7% | 4.4% | |
| Peer median (excluding HQY) | $74.71M | -19.4% | -25.2% | 11.2% | |
Competitors are the stored peer set for HQY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 225.41M | 254.27M | 403.98M | 295.95M | 318.93M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 87.43M | 96.84M | 104.89M | 118.01M | 123.7M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 38.5M | 31.79M | 48.56M | 63.8M | 69.66M |
| Total Current Assets | 351.34M | 382.89M | 557.44M | 477.75M | 512.28M |
| Property, Plant & Equipment (Net) | 86.99M | 69.32M | 54.39M | 46.42M | 39.49M |
| Goodwill | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B |
| Intangible Assets | 973.14M | 936.36M | 835.95M | 1.2B | 1.1B |
| Long-term Investments | 0 | 0 | 0 | 0 | 3.29M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 49.81M | 52.18M | 67.87M | 71.57M | 131.67M |
| Total Non-current Assets | 2.76B | 2.71B | 2.61B | 2.97B | 2.92B |
| Total Assets | 3.11B | 3.09B | 3.16B | 3.45B | 3.43B |
| Account Payables | 27.54M | 13.9M | 12.04M | 14.36M | 12.16M |
| Short-term Debt | 8.75M | 17.5M | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 47.14M | 45.84M | 49.61M | 69.33M | 60.39M |
| Total Current Liabilities | 153.19M | 131.06M | 117.09M | 156.32M | 156.85M |
| Long-term Debt | 922.08M | 907.84M | 874.97M | 1.06B | 957.38M |
| Deferred Tax Liabilities | 99.85M | 82.67M | 68.67M | 55.83M | 145.42M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 14.19M | 12.71M | 19.27M | 22.96M | 31.01M |
| Total Non-current Liabilities | 1.1B | 1.06B | 1.01B | 1.18B | 1.17B |
| Total Liabilities | 1.25B | 1.19B | 1.13B | 1.33B | 1.32B |
| Common Stock | 8K | 8K | 9K | 9K | 8K |
| Retained Earnings | 176.06M | 149.92M | 205.63M | 209.27M | 195.91M |
| Accumulated OCI | 0 | 0 | 0 | 0 | (5.71M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.85B | 1.9B | 2.04B | 2.11B | 2.11B |
| Total Debt | 1.01B | 994.49M | 933.14M | 1.11B | 1B |
| Net Debt | 782.82M | 740.22M | 529.16M | 812.57M | 682.55M |
HealthEquity, Inc.
NASDAQ:HQY
Intrinsic Alpha fair value
Locked
Current Price
$97.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.